Efficacy of Artesunate-Mefloquine Combination Therapy in Trat Province, Thailand
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to compare artesunate-mefloquine combination therapy given
for 2 and 3 days at the same total dose for the treatment of uncomplicated falciparum
malaria.
Phase:
N/A
Details
Lead Sponsor:
Armed Forces Research Institute of Medical Sciences, Thailand